# Omron Ventures

> Omron Ventures is a VC fund in Minato backing Health Care and Medical. See 23 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Minato, Japan
- Total investments: 23
- Last investment: Jun 2026
- Lead investor: 30%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/omronventurescoltd
- Website: https://www.omron.com/ventures

Omron Ventures is a corporate venture capital firm that invests and drives the growth of invested start-ups. It was Kazuma Tateishi, founder of OMRON, who established Kyoto Enterprise Development (KED, 1972-1979), known to be the oldest private venture capital firm in Japan.

## Contacts

5 contacts available for Omron Ventures. Shizune tracks 1 team members at Omron Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/omron-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 35% |
| Medical | 5 | 22% |
| Robotics | 5 | 22% |
| Software | 3 | 13% |
| Biotechnology | 3 | 13% |

40 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 7 | 30% |
| Series B | 5 | 22% |
| Seed | 3 | 13% |
| Funding Round | 3 | 13% |
| Venture - Series Unknown | 2 | 9% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 7 | 30% |
| United States | 3 | 13% |
| United Kingdom | 3 | 13% |
| Israel | 2 | 9% |
| India | 1 | 4% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kazuma Tateisi | Founder | 0 | https://shizune.co/investors/profile/kazuma-tateisi |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Smart Craft |  |  | Seed | Jun 11, 2026 |  |
| HQ | HQ offers next-generation employee benefits platform. | $13.1M | Series B | Dec 12, 2024 |  |
| avatarin | avatarin develops next-generation mobility and human augmentation platforms. | $23.5M | Series B | Jul 18, 2024 |  |
| Sanome | Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people. |  | Seed | Jan 01, 2024 |  |
| Rehab | Rehab develops a rehabilitation support SaaS "Rehaplan" for adult day care centers. | $8.8M | Series D | Feb 01, 2023 |  |
| Eagle Genomics | Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of softwareproducts radically reduces cost and time to complete research, enabling drastic productivity improvements.Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era. |  | Venture - Series Unknown | Jan 16, 2023 |  |
| PhableCare | PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcaresystem. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring. | $24.7M | Series B | Apr 11, 2022 |  |
| ClimateTrade | ClimateTrade is a blockchain-based carbon credits trading platform. Their vision is to be the most disruptive and exponential fintech company in the environmental sector to accelerate the achievement of the Sustainable Development Goals, focusing on the client. They have built an ecosystem where companies and consumers can easily offset theircarbon footprint and also access to other climate related products. Their API is the first Carbon API created in the world and allows companies to offer products and services carbon neutral and be certified in blockchain. | $7.9M | Seed | Jan 24, 2022 |  |
| Cogsmart | Cogsmart provides services for brain function research and development. In hopes of helping prevent dementia and maintain and improve other cognitive functions, they manufacture and sell software for medical and healthcare devices. | $3M | Series A | Jan 06, 2022 |  |
| PhableCare | PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcaresystem. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring. | $1.9M | Series A | Sep 09, 2021 |  |

10 of 23 investments shown.

## Co-investors
- [Duke Angel Network](https://shizune.co/investors/profile/duke-angel-net) — VC Fund, 2 deals together
- [Fuyo General Lease](https://shizune.co/investors/profile/fuyo-general-lease) — VC Fund, 2 deals together
- [Globespan Capital Partners](https://shizune.co/investors/profile/globespan-capital-partners) — VC Fund, 2 deals together
- [Hyundai Motor Company](https://shizune.co/investors/profile/hyundai-motor-company) — VC Fund, 2 deals together
- [Intel Corporation](https://shizune.co/investors/profile/intel-corporation-ltd) — VC Fund, 2 deals together
- [Japan Post Bank Asset Management](https://shizune.co/investors/profile/japan-post-investment) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Omron Ventures invest in?

Omron Ventures invests primarily in Health Care, Medical and Robotics startups, most often at Series A and Series B stage. Most of the 23 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Omron Ventures?

Public channels for Omron Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Omron Ventures?

The team at Omron Ventures includes Kazuma Tateisi (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co